Fig. 3From: Synthesis, radiosynthesis, in vitro and first in vivo evaluation of a new matrix metalloproteinase inhibitor based on γ-fluorinated α-sulfonylaminohydroxamic acidIn vivo biodistribution of tracer-associated radioactivity after intravenous injection of (S)-[18F]9aBack to article page